CSI Market
Sign In | Register

Intelligent Bio Solutions Inc (INBS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INBS quarterly Cash Flow →
The table below presents a historical view of Intelligent Bio Solutions Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
12 Months 		(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Operating Activities
Income-12.47
Depreciation & amortization1.23
Amortization of Other Assets1.15
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of0.30
Provision For Loan Losses Expensed0.01
Inventories Decrease /-Increase-0.15
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.29
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.04
Contingent Beneficial Conversion Feature On Convertible Notes-
Money Received For Which Preference Shares Were Issued After Yearend-
Increase Decrease In Research And Development Tax Incentive Receivable-0.21
Noncash Loss On Foreign Currency Translation Net-
Non Cash Refund Of Rd Expenditure Claims-
Finance Lease Right Of Use Asset Amortization0.24
Noncash Gain Loss On Foreign Currency Translation Net-
Non Cash Refund Of Research And Development Expenditure Claims-
Fair Value Gain On Revaluation Of Financial Instruments-
Increase Decrease In Other Payable-
Noncash Refund Of Research And Development Rd Expenditure Claims-0.14
Increase Decrease In Operating Lease Liability-0.27
Noncash Other Operating Activities0.11
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.43
Increase (Decrease) in Other Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Deferred Charges0.00
Other Working Capital0.17
Other Noncash Income (Expense)0.00
Other net-0.04
Payments for (Proceeds from) Other Operating Activities-2.03
Discontinued operations0.00
Net Cash flow from Operating Activities-11.93
Investing Activities
Capital Expenditures-0.13
Sale of Capital Items0.04
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Amount Invested On Capital Work In Progress-
Cash Acquired From Business Acquisition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.09
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock10.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net4.98
Proceeds From Warrant Holders For Common Shares-
Reclassification Of Deferred Charges To Additional Paid In Capital Upon Completion Of Initial Public Offering-
Conversion Of Stock Amount Converted-
Conversion Of Preferred Shares Into Common Shares-
Payment Of Tax Withholding For Employee Stock Awards-
Finance Lease Principal Payments-
Proceeds From Issuance Of Common Stock And Warrants4.59
Payment Of Equity Issuance Costs Relating To Acquisition-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities14.98
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-12.01
Total Cash Flow2.97
4 historic quarters locked

Sign in to unlock the full Intelligent Bio Solutions Inc cash flow history.

Sign In Create Free Account

About Intelligent Bio Solutions Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20260630)
  • Filed with the SEC: August 19, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-039136

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License